Biological Activity in vitro and in vivo , effectively reducing oxidative stress, apoptosis , and ferroptosis in hair cells
Pain Sensation: Patients can experience pain or tenderness that can last for a few hours or a few days
The SURMOUNT-1 trial showed that participants receiving the highest dose of tirzepatide (15 mg) lost an average of 22.5% of their body weight over 72 weeks
The key concern is that people who start GLP-1 medications may differ in important ways from people starting other diabetes drugs. People who are starting GLP-1s could be more motivated to change their behaviors, be more engaged with their health care or receive more intensive follow-up from clinicians, Alexander said
doi:10.1016/j.jad.2011.04.051
Disclaimer The views and opinions expressed are those of the authors and do not necessarily reflect the official policy or position of HealthCareInsider.com or HealthCare, Inc